Scotia Institutional Investments US’s Jazz Pharmaceuticals JAZZ Stock Holding History

Scotia Institutional Investments US’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	$16.1M	Buy	+175,025	New	+$14.1M	14.37%	1

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

Scotia Institutional Investments US's JAZZ Position: Q3 2013 in Review

Scotia Institutional Investments US opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2013: 175,025 shares worth $16.1M. The stake represents 14.37% of the portfolio and ranks #1 among its holdings.

249 funds tracked by Wall St. Rank hold JAZZ as of Q3 2013.

Scotia Institutional Investments US held 175,025 shares of Jazz Pharmaceuticals worth $16.1M as of Q3 2013.
Jazz Pharmaceuticals was a new Scotia Institutional Investments US position in Q3 2013.
Jazz Pharmaceuticals made up 14.37% of Scotia Institutional Investments US's portfolio in Q3 2013, its #1 holding.
249 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2013.

Based on Scotia Institutional Investments US's 13F filing for Q3 2013, filed 14 Nov 2013.